✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹7,846 Cr.
P/E
28.80

Key Ratios

Market cap
Market cap
7,846 Cr
PE
PE
28.80
Prom Holding
Prom Holding
43.72 %
ROE (%)
ROE (%)
12.34
ROCE (%)
ROCE (%)
16.83
Div Yield (%)
Div Yield (%)
0.29
Sales
Sales
2,115 Cr
OPM (%)
OPM (%)
21.96 %
Debt to Equity
Debt to Equity
0.15
About
Aarti Pharmalabs Limited, formerly Aarti Organics Limited, is a prominent Indian pharmaceutica… Read more
Low
557
52W Range
High
971
  • Aarti Pharmalabs
  • Shilpa Medicare
  • Acutaas Chemicals

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

5 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Segment

Peer Comparison
Corporate Actions
Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less
FAQs on Aarti Pharmalabs Ltd. Business

Aarti Pharmalabs Limited is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals, focusing on Active Pharmaceutical Ingredients and xanthine derivatives, leveraging process chemistry expertise and scale-up engineering.

Aarti Pharmalabs major competitors are Shilpa Medicare, Acutaas Chemicals, Supriya Lifescience, Granules India, Aarti Drugs, Alivus Life Sciences, Morepen Laboratories.
Market Cap of Aarti Pharmalabs is ₹8,268 Crs.
While the median market cap of its peers are ₹8,642 Crs.

Aarti Pharmalabs seems to be less financially stable compared to its competitors.
Altman Z score of Aarti Pharmalabs is 8.35 and is ranked 4 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation May Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Mar Mar Jun Sep Dec Jun Sep Dec
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material